Glaxosmithkline (GSK)

 

Latest News

GlaxoSmithKline joint venture's HIV treatment approved in Europe

GlaxoSmithKline said a HIV treatment developed by its ViiV Healthcare joint venture with Pfizer and Shionogi had been ...

ViiV granted EU marketing authorisation for Juluca

RNS Number: 7216O GlaxoSmithKline PLC 21 May 2018 Issued: 21 may 2018, London UK - LSE Announcement ViiV Healthcare receives EU marketing authorisation for Juluca (dolutegravir/rilpivirine), the first 2-drug regimen, once-daily, single-pill for the treatment of HIV Juluca maintains viral suppression with two drugs in the smallest single pill regimen Londo...

Director/PDMR Shareholding

RNS Number: 1568O GlaxoSmithKline PLC 15 May 2018 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Mr P Thomson b) Position/status President, Global Affairs c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market participant, ...

Director/PDMR Shareholding

RNS Number: 8651N GlaxoSmithKline PLC 11 May 2018 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Ms E Walmsley b) Position/status Chief Executive Officer c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market participant, a...

All News

DateHeadlineSource
21-05-18GlaxoSmithKline joint venture's HIV treatment approved in EuropeStockMarketWire
21-05-18ViiV granted EU marketing authorisation for JulucaRNS
15-05-18Director/PDMR ShareholdingRNS
11-05-18Director/PDMR ShareholdingRNS
10-05-18Block listing Interim ReviewRNS
09-05-18Director/PDMR Shareholding - replacementRNS
09-05-18Directorate ChangeRNS
09-05-18Most popular FTSE 100, AIM and overseas shares in April 2018Interactive Investor
03-05-18Result of General MeetingRNS
03-05-18Result of AGMRNS
01-05-18Total Voting RightsRNS
27-04-18Broker Forecast - Deutsche Bank issues a broker note on GlaxoSmithKline PLCStockMarketWire
27-04-18Director/PDMR ShareholdingRNS
27-04-18Broker Forecast - Berenberg issues a broker note on GlaxoSmithKline PLCStockMarketWire
26-04-18Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
26-04-18Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
26-04-18Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
26-04-18Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
26-04-18Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
26-04-18Broker Forecast - Barclays Capital issues a broker note on GlaxoSmithKline PLCStockMarketWire
26-04-18Director/PDMR ShareholdingRNS
25-04-18Downbeat global performance stifles FTSEStockMarketWire
25-04-18Is GlaxoSmithKline dive overdone?Interactive Investor
25-04-18GlaxoSmithKline profit falls 38%, warns of asthma treatment sales slipStockMarketWire
25-04-18Second Price Monitoring ExtnRNS
25-04-18Price Monitoring ExtensionRNS
25-04-181st Quarter ResultsRNS
24-04-18Trelegy Ellipta expanded US COPD indicationRNS
20-04-18The week ahead: Lloyds, banks, Glaxo, ShellInteractive Investor
20-04-18Director/PDMR ShareholdingRNS
20-04-18Director/PDMR ShareholdingRNS
19-04-18GlaxoSmithKline IMPACT study shows significant benefits of Trelegy Ellipta for COPD patientsStockMarketWire
19-04-18IMPACT study shows benefits of Trelegy ElliptaRNS
18-04-18Landmark IMPACT study to be published in NEJMRNS
18-04-18IMPACT study shows benefits of Trelegy ElliptaRNS
17-04-18Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
17-04-18Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
17-04-18Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
17-04-18Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
17-04-18Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire

RSS feeds

  • Editorial news feed for LSE:GSK Editorial
  • Regulatory news feed for LSE:GSK Regulatory